AtriCure to Participate in the Stifel 2024 Healthcare Conference
AtriCure (Nasdaq: ATRC), a company specializing in surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management, has announced its participation in the Stifel 2024 Healthcare Conference. The company's management will engage in a fireside chat on Monday, November 18, 2024, at 9:10 am EST. A live audio webcast of the presentation will be accessible through the 'Investors' section of AtriCure's website.
AtriCure (Nasdaq: ATRC), un'azienda specializzata in trattamenti chirurgici per fibrillazione atriale, gestione dell'appendice atriale sinistra e gestione del dolore post-operatorio, ha annunciato la sua partecipazione alla Stifel 2024 Healthcare Conference. La direzione dell'azienda parteciperà a una chiacchierata informale il lunedì 18 novembre 2024, alle 9:10 EST. Una trasmissione audio live della presentazione sarà accessibile attraverso la sezione 'Investitori' del sito web di AtriCure.
AtriCure (Nasdaq: ATRC), una empresa especializada en tratamientos quirúrgicos para fibrilación auricular, manejo de la appendice auricular izquierda y manejo del dolor postoperatorio, ha anunciado su participación en la Stifel 2024 Healthcare Conference. La dirección de la empresa participará en una charla informal el lunes 18 de noviembre de 2024, a las 9:10 am EST. Una transmisión de audio en vivo de la presentación estará disponible a través de la sección 'Inversores' del sitio web de AtriCure.
AtriCure (Nasdaq: ATRC)는 심방세동, 좌심방 부속기 관리, 수술 후 통증 관리에 대한 외과적 치료를 전문으로 하는 회사로, Stifel 2024 Healthcare Conference에 참여한다고 발표했습니다. 회사의 경영진은 2024년 11월 18일 월요일 오전 9시 10분 EST에 화기애애한 대화에 참여할 예정입니다. 발표의 라이브 오디오 웹캐스트는 AtriCure 웹사이트의 '투자자' 섹션을 통해 접근할 수 있습니다.
AtriCure (Nasdaq: ATRC), une entreprise spécialisée dans les traitements chirurgicaux pour fibrillation auriculaire, la gestion de l'appendice auriculaire gauche et la gestion de la douleur post-opératoire, a annoncé sa participation à la Stifel 2024 Healthcare Conference. La direction de l'entreprise participera à une discussion informelle le lundi 18 novembre 2024, à 9h10 EST. Un webinaire audio en direct de la présentation sera accessible via la section 'Investisseurs' du site Web d'AtriCure.
AtriCure (Nasdaq: ATRC), ein Unternehmen, das sich auf chirurgische Behandlungen von Vorhofflimmern, das Management des linken Vorhofohrchens und die postoperative Schmerzbehandlung spezialisiert hat, hat seine Teilnahme an der Stifel 2024 Healthcare Conference bekannt gegeben. Das Management des Unternehmens wird am Montag, den 18. November 2024, um 9:10 Uhr EST an einem informellen Gespräch teilnehmen. Ein Live-Audio-Webcast der Präsentation wird über den Bereich 'Investoren' auf der Website von AtriCure zugänglich sein.
- None.
- None.
AtriCure’s management is scheduled to participate in a fireside chat on Monday, November 18, 2024, at 9:10 am Eastern Standard Time. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at https://ir.atricure.com
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241107221308/en/
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
awirick@atricure.com
Marissa Bych
Gilmartin Group
Investor Relations
marissa@gilmartinir.com
Source: AtriCure, Inc.
FAQ
When is AtriCure (ATRC) presenting at the Stifel 2024 Healthcare Conference?
How can investors watch AtriCure's (ATRC) presentation at the Stifel 2024 Healthcare Conference?
What type of presentation will AtriCure (ATRC) give at the Stifel 2024 Healthcare Conference?
What medical conditions does AtriCure (ATRC) focus on treating?
